While HER2 is the most common target identified in breast cancer, other major targets include, adenosine receptor targets, nonspecific tumor-associated antigens (TAA), immune checkpoints (PD-1, PD-L1), toll-like receptors (TLRs), and colony-stimulating factor-1 (CSF1/R). This evidence concerns the gene CD274 and breast cancer.